Paysign Reports Record Third Quarter 2026 Financial Results

Paysign reported record third-quarter 2026 revenue of $30.80 million, up 42.6% year over year, while its operating margin more than tripled to 23.8%. Pharma revenue rose 109.8% to $16.62 million, supported by 62 net new patient programs. Earnings per share were $0.11, above the FactSet consensus estimate of $0.09.